PT3580567T - Método para o diagnóstico in vitro do cancro do pulmão - Google Patents

Método para o diagnóstico in vitro do cancro do pulmão

Info

Publication number
PT3580567T
PT3580567T PT187037841T PT18703784T PT3580567T PT 3580567 T PT3580567 T PT 3580567T PT 187037841 T PT187037841 T PT 187037841T PT 18703784 T PT18703784 T PT 18703784T PT 3580567 T PT3580567 T PT 3580567T
Authority
PT
Portugal
Prior art keywords
diagnosis
lung cancer
vitro method
vitro
lung
Prior art date
Application number
PT187037841T
Other languages
English (en)
Original Assignee
Fundacion Para La Investig Medica Aplicada
Advanced Marker Discovery S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Para La Investig Medica Aplicada, Advanced Marker Discovery S L filed Critical Fundacion Para La Investig Medica Aplicada
Publication of PT3580567T publication Critical patent/PT3580567T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT187037841T 2017-02-08 2018-02-08 Método para o diagnóstico in vitro do cancro do pulmão PT3580567T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382054.9A EP3361256A1 (en) 2017-02-08 2017-02-08 In vitro method for the diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
PT3580567T true PT3580567T (pt) 2021-07-14

Family

ID=58043996

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187037841T PT3580567T (pt) 2017-02-08 2018-02-08 Método para o diagnóstico in vitro do cancro do pulmão

Country Status (11)

Country Link
US (1) US20200025765A1 (pt)
EP (2) EP3361256A1 (pt)
CN (1) CN110770584B (pt)
AU (1) AU2018217372B2 (pt)
CA (1) CA3052529A1 (pt)
DK (1) DK3580567T3 (pt)
ES (1) ES2880761T3 (pt)
HU (1) HUE054864T2 (pt)
PL (1) PL3580567T3 (pt)
PT (1) PT3580567T (pt)
WO (1) WO2018146232A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021213150A1 (en) 2020-01-30 2022-08-04 Prognomiq Inc Lung biomarkers and methods of use thereof
JP2023545017A (ja) * 2020-10-02 2023-10-26 ボード オブ レジェンツ，ザ ユニバーシティ オブ テキサス システム 肺がんの検出及び治療のための方法
GB2607436A (en) * 2021-03-31 2022-12-07 Prognomiq Inc Multi-omic assessment
JP2024534992A (ja) 2021-09-13 2024-09-26 プログノミック インコーポレイテッド 生体分子の増強された検出および定量

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE465275T1 (de) * 2003-06-13 2010-05-15 Univ Pittsburgh Überwachung von immunologischen, hämatologischen und entzündlichen erkrankungen
MX349562B (es) * 2011-12-09 2017-08-02 Pasteur Institut Ensayo de inmuno deteccion multiplex.
US9201044B2 (en) * 2011-12-21 2015-12-01 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
WO2013143940A1 (en) * 2012-03-29 2013-10-03 Proyecto De Biomedicina Cima, S.L. New lung cancer molecular markers

Also Published As

Publication number Publication date
CA3052529A1 (en) 2018-08-16
AU2018217372A1 (en) 2019-09-12
US20200025765A1 (en) 2020-01-23
CN110770584A (zh) 2020-02-07
DK3580567T3 (da) 2021-07-12
AU2018217372B2 (en) 2024-01-25
EP3580567B1 (en) 2021-04-07
EP3361256A1 (en) 2018-08-15
HUE054864T2 (hu) 2021-10-28
CN110770584B (zh) 2023-06-13
WO2018146232A1 (en) 2018-08-16
ES2880761T3 (es) 2021-11-25
EP3580567A1 (en) 2019-12-18
PL3580567T3 (pl) 2021-12-06

Similar Documents

Publication Publication Date Title
HK1250376A1 (zh) 用於癌症的治療和診斷方法
HK1248773A1 (zh) 用於癌症的治療和診斷方法
IL250507A0 (en) Anti-ck8 antibodies for use in cancer therapy
EP3149210A4 (en) Method and systems for lung cancer diagnosis
EP3298145A4 (en) Method of diagnosis of breast cancer
PT3580567T (pt) Método para o diagnóstico in vitro do cancro do pulmão
ZA202000851B (en) Antibodies useful in cancer diagnosis
HK1243434A1 (zh) Igf-1r抗體及其診斷癌症的用途
PT3298165T (pt) Método e kit para diagnóstico de cancro colorretal
HK1248730A1 (zh) Igf-1r抗體及其用於癌症診斷的用途
RS63600B1 (sr) Postupci za dijagnostikovanje aneurizme ili kancera
ZA202107946B (en) Methods for the diagnosis of lung cancer
HUP1800440A2 (hu) In vitro eljárás rosszindulatú állapotok diagnosztizálására